Respiratory syncytial virus (RSV) outbreak in the NICU: description of eight cases

Ramzi A Kilani1

  • 1Department of Pediatrics, King Khaled University Hospital-King Saud University, Riyadh, Saudi Arabia. ramkilani@yahoo.com

Insights

Preterm infants, especially those born earlier, face higher risks during respiratory syncytial virus (RSV) outbreaks in neonatal ICUs. These vulnerable infants experienced increased illness, severe complications, and mortality, underscoring the need for targeted prevention.

Area of Science:

  • Neonatology
  • Pediatric Infectious Diseases
  • Virology

Background:

  • Respiratory syncytial virus (RSV) is a significant nosocomial pathogen in pediatric settings.
  • Term neonates typically have lower symptomatic RSV infection rates due to maternal antibodies.
  • Neonatal intensive care units (NICUs) are vulnerable environments for RSV transmission.

Purpose of the Study:

  • To investigate the attack rate and clinical outcomes of RSV infection in neonates during an outbreak.
  • To compare RSV susceptibility between term and preterm infants in a NICU setting.
  • To evaluate the impact of gestational age on RSV severity in neonates.

Main Methods:

  • Retrospective analysis of an RSV outbreak in a NICU.
  • Categorization of infants based on gestational age (term vs. preterm).
  • Monitoring of RSV infection status, clinical presentation, and outcomes.

Main Results:

  • Preterm infants (gestational age 28 +/- 2 weeks) had a higher RSV attack rate compared to term infants (gestational age 34 +/- 5 weeks).
  • Four preterm infants developed severe RSV illness requiring mechanical ventilation.
  • Two preterm infants developed acute respiratory distress syndrome (ARDS), with one fatality.

Conclusions:

  • Preterm infants, particularly those with lower gestational ages, are at increased risk of severe RSV infection and adverse outcomes in the NICU.
  • RSV outbreaks in NICUs pose a significant threat to vulnerable preterm populations.
  • Effective control measures are crucial for mitigating RSV transmission and impact in neonatal units.

Related Concept Videos

Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...